World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 27 February 2017
Main ID:  ISRCTN18100534
Date of registration: 03/02/2017
Prospective Registration: No
Primary sponsor: National Natural Science Foundation of China
Public title: Progranulin induces autophagy disorder in type 2 diabetic nephropathy
Scientific title: PGRN Links Autophagy: Etiology study of Type 2 diabetic nephropathy
Date of first enrolment: 01/08/2014
Target sample size: 154
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN18100534
Study type:  Observational
Study design:  Observational cohort study (Screening)  
Phase: 
Countries of recruitment
Afghanistan
Contacts
Name: Hongzhi    Sun
Address:  Medical School of Xi’an Jiaotong University 76 Yanta West Road 710061 Xi’an China
Telephone: +86 29 0826 55046
Email: sunhongzhi@mail.xjtu.edu.cn
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients:
1. Aged between 20 and 80 years old
2. Diagnosed with type 2 diabetes mellitus

Controls:
1. Aged between 32 and 72 years
2. Normal glucose control

Exclusion criteria: 1. Past history of malignancy
2. Degenerative disease of the nervous system
3. Diabetic macrovascular complications
4. Other endocrine diseases which affect glucose metabolism and lipid metabolism
5. Chronic hepatitis
6. Primary kidney disease
7. Recent inflammatory disease
8. Acute trauma
9. Taking thiazolidinedione drugs in the previous 3 weeks
10. Pregnancy
11. History of drug abuse.


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Diabetic nephropathy
Urological and Genital Diseases
Diabetic nephropathy
Intervention(s)
A total of 134 patients with type 2 diabetes and 20 participants with normal glucose tolerance are enrolled. Patients with type 2 diabetes are divided into three groups based on their urinary albumin excretion rate (UAER): simple diabetes mellitus (SDM), early diabetic nephropathy (EDN), and clinical diabetic nephropathy (CDN).

All participants one study visit and provide blood samples when they visit to measure serum PGRN, plasma glucose, plasma insulin and HbA1c. Serum concentrations of PGRN are measured using ELISA.

Renal tissue is obtained from six living allograft donors and 12 diabetic nephropathy patients (taken from the existing participant groups). Autophagy indicators Atg7, LC3, and p62 of renal tissue are detected by Real-time PCR and western blotting.
Primary Outcome(s)
1. PGRN serum concentration is measured using ELISAs at baseline and 2 hours after overnight fasting
2. Plasma glucose is measured using glucose oxidase method at baseline and 2 hours after overnight fasting
3. Serum insulin is measured using radioimmunoassay at baseline and 2 hours after overnight fasting
4. HbA1c values are measured using high-performance liquid chromatography at baseline and 2 hours after overnight fasting
Secondary Outcome(s)
Autophagy indicators Atg7, LC3, and p62 of renal tissue are measured using immunohistochemical examination, real-time PCR and western blotting at baseline, 0, 10, 20 and 40 minutes after overnight fasting.
Secondary ID(s)
2014074
Source(s) of Monetary Support
National Natural Science Foundation of China, The New Century Excellent Talentsin University from the Ministry of Education
Secondary Sponsor(s)
The New Century Excellent Talentsin University from the Ministry of Education
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history